1-7 of 7
Jan Alsner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract RF2-05: Validation of the association between TILs, ER status and benefit of radiotherapy in node positive, breast cancer patients: a DBCG study

Free
Demet Özcan, Anders W.M. Nielsen, Jan Alsner, Else Maae, Mette H. Nielsen, Lars Stenbygaard, Lise B.J. Thorsen, Jens Overgaard, Birgitte V. Offersen, Trine Tramm
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (12_Supplement): RF2-05.
https://doi.org/10.1158/1557-3265.SABCS24-RF2-05
Published: 13 June 2025
View articletitled, Abstract RF2-05: Validation of the association between TILs, ER status and benefit of radiotherapy in node positive, breast cancer patients: a DBCG study
Journal Articles

A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients

Free
Lingjian Yang, Janet Taylor, Amanda Eustace, Joely J. Irlam, Helen Denley, Peter J. Hoskin, Jan Alsner, Francesca M. Buffa, Adrian L. Harris, Ananya Choudhury, Catharine M.L. West
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (16): 4761–4768.
https://doi.org/10.1158/1078-0432.CCR-17-0038
Published: 14 August 2017
View articletitled, A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients
Open the PDF for A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Integrative Analysis of DCE-MRI and Gene Expression Profiles in Construction of a Gene Classifier for Assessment of Hypoxia-Related Risk of Chemoradiotherapy Failure in Cervical Cancer

Free
Christina S. Fjeldbo, Cathinka H. Julin, Malin Lando, Malin F. Forsberg, Eva-Katrine Aarnes, Jan Alsner, Gunnar B. Kristensen, Eirik Malinen, Heidi Lyng
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (16): 4067–4076.
https://doi.org/10.1158/1078-0432.CCR-15-2322
Published: 14 August 2016
View articletitled, Integrative Analysis of DCE-MRI and Gene Expression Profiles in Construction of a Gene Classifier for Assessment of Hypoxia-Related Risk of Chemoradiotherapy Failure in Cervical Cancer
Open the PDF for Integrative Analysis of DCE-MRI and Gene Expression Profiles in Construction of a Gene Classifier for Assessment of Hypoxia-Related Risk of Chemoradiotherapy Failure in Cervical Cancer in another window
Includes: Supplementary data
Journal Articles

Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(−) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG

Free
Annett Linge, Steffen Löck, Volker Gudziol, Alexander Nowak, Fabian Lohaus, Cläre von Neubeck, Martin Jütz, Amir Abdollahi, Jürgen Debus, Inge Tinhofer, Volker Budach, Ali Sak, Martin Stuschke, Panagiotis Balermpas, Claus Rödel, Melanie Avlar, Anca-Ligia Grosu, Christine Bayer, Claus Belka, Steffi Pigorsch, Stephanie E. Combs, Stefan Welz, Daniel Zips, Frank Buchholz, Daniela E. Aust, Gustavo B. Baretton, Howard D. Thames, Anna Dubrovska, Jan Alsner, Jens Overgaard, Michael Baumann, Mechthild Krause
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (11): 2639–2649.
https://doi.org/10.1158/1078-0432.CCR-15-1990
Published: 31 May 2016
View articletitled, Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(−) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG
Open the PDF for Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(−) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG in another window
Includes: Supplementary data
Journal Articles

Development and Validation of a Gene Profile Predicting Benefit of Postmastectomy Radiotherapy in Patients with High-Risk Breast Cancer: A Study of Gene Expression in the DBCG82bc Cohort

Free
Trine Tramm, Hayat Mohammed, Simen Myhre, Marianne Kyndi, Jan Alsner, Anne-Lise Børresen-Dale, Therese Sørlie, Arnoldo Frigessi, Jens Overgaard
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (20): 5272–5280.
https://doi.org/10.1158/1078-0432.CCR-14-0458
Published: 14 October 2014
View articletitled, Development and Validation of a Gene Profile Predicting Benefit of Postmastectomy Radiotherapy in Patients with High-Risk Breast Cancer: A Study of Gene Expression in the DBCG82bc Cohort
Open the PDF for Development and Validation of a Gene Profile Predicting Benefit of Postmastectomy Radiotherapy in Patients with High-Risk Breast Cancer: A Study of Gene Expression in the DBCG82bc Cohort in another window
Includes: Supplementary data
Journal Articles

Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer

Free
Roshan Agarwal, Ana-Maria Gonzalez-Angulo, Simen Myhre, Mark Carey, Ju-Seog Lee, Jens Overgaard, Jan Alsner, Katherine Stemke-Hale, Ana Lluch, Richard M. Neve, Wen Lin Kuo, Therese Sorlie, Aysegul Sahin, Vicente Valero, Khandan Keyomarsi, Joe W. Gray, Anne-Lise Borresen-Dale, Gordon B. Mills, Bryan T. Hennessy
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (11): 3654–3662.
https://doi.org/10.1158/1078-0432.CCR-08-3293
Published: 01 June 2009
View articletitled, Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer
Open the PDF for Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Heterogeneity in the Clinical Phenotype of TP53 Mutations in Breast Cancer Patients

Free
Jan Alsner, Mette Yilmaz, Per Guldberg, Lise Lotte Hansen, Jens Overgaard
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (10): 3923–3931.
Published: 01 October 2000
View articletitled, Heterogeneity in the Clinical Phenotype of TP53 Mutations in Breast Cancer Patients
Open the PDF for Heterogeneity in the Clinical Phenotype of TP53 Mutations in Breast Cancer Patients in another window